SANTA MONICA, Calif.--(BUSINESS WIRE)-- Kite Pharma, Inc., (Nasdaq:KITE) today announced that management will participate in a panel at the 11th Annual Citi Biotech Conference and a fireside chat discussion at the Morgan Stanley Global Healthcare Conference.
11th Annual Citi Biotech Conference |
o Date: Wednesday, September 7, 2016 |
o Time: 2:00 PM Eastern Time |
o Location: Boston, MA |
Morgan Stanley Global Healthcare Conference |
o Date: Tuesday, September 13, 2016 |
o Time: 1:30 PM Eastern Time |
o Location: New York, NY |
A live audio webcast of each event will be available on the Investors section of Kite's website, www.kitepharma.com. A replay of each webcast will be available on the website for approximately 30 days.
About Kite Pharma
Kite Pharma, Inc. is a clinical-stage biopharmaceutical company engaged in the development of novel cancer immunotherapy products, with a primary focus on engineered autologous cell therapy (eACT™) designed to restore the immune system's ability to recognize and eradicate tumors. Kite is based in Santa Monica, CA. For more information on Kite Pharma, please visit www.kitepharma.com. Sign up to follow @KitePharma on Twitter at www.twitter.com/kitepharma.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160831006261/en/
Kite PharmaGreg MannVP, Investor Relationsgmann@kitepharma.comorFor Media:inVentiv HealthDavid Polk, 310-309-1029david.polk@inventivhealth.com
Source: Kite Pharma, Inc.
News Provided by Acquire Media
